Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP

Invest Ophthalmol Vis Sci. 2005 Sep;46(9):3039-45. doi: 10.1167/iovs.05-0371.

Abstract

Purpose: Retinitis pigmentosa GTPase regulator (RPGR) is a photoreceptor protein anchored in the connecting cilia by an RPGR-interacting protein (RPGRIP). Loss of RPGRIP causes Leber congenital amaurosis (LCA), a severe form of photoreceptor degeneration. The current study was an investigation of whether somatic gene replacement could rescue degenerating photoreceptors in a murine model of LCA due to a defect in RPGRIP.

Methods: An RPGRIP expression cassette, driven by a mouse opsin promoter, was packaged into recombinant adeno-associated virus (AAV). The AAV vector was delivered into the right eyes of RPGRIP(-/-) mice by a single subretinal injection into the superior hemisphere. The left eyes received a saline injection as a control. Full-field electroretinograms (ERGs) were recorded from both eyes at 2, 3, 4, and 5 months after injection. After the final follow-up, retinas were analyzed by immunostaining or by light and electron microscopy.

Results: Delivery of the AAV vector led to RPGRIP expression and restoration of normal RPGR localization at the connecting cilia. Photoreceptor preservation was evident by a thicker cell layer and well-developed outer segments in the treated eyes. Rescue was more pronounced in the superior hemisphere coincident with the site of delivery. Functional preservation was demonstrated by ERG.

Conclusions: AAV-mediated RPGRIP gene replacement preserves photoreceptor structure and function in a mouse model of LCA, despite ongoing cell loss at the time of intervention. These results indicate that gene replacement therapy may be effective in patients with LCA due to a defect in RPGRIP and suggest that further preclinical development of gene therapy for this disorder is warranted.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Blindness / congenital
  • Blindness / metabolism
  • Blindness / therapy*
  • Cytoskeletal Proteins
  • Dependovirus / genetics
  • Disease Models, Animal
  • Electroretinography
  • Eye Proteins / genetics
  • Eye Proteins / metabolism
  • Fluorescent Antibody Technique, Indirect
  • Gene Expression Regulation / physiology*
  • Genetic Therapy*
  • Genetic Vectors
  • Green Fluorescent Proteins / genetics
  • Mice
  • Mice, Knockout
  • Photoreceptor Cells, Vertebrate / metabolism*
  • Photoreceptor Cells, Vertebrate / ultrastructure
  • Promoter Regions, Genetic
  • Proteins / genetics*
  • Proteins / metabolism
  • Retinal Degeneration / metabolism
  • Retinal Degeneration / pathology
  • Retinal Degeneration / therapy*
  • Rod Opsins / genetics
  • Transfection

Substances

  • Cytoskeletal Proteins
  • Eye Proteins
  • Proteins
  • RPGR protein, human
  • RPGRIP1 protein, human
  • Rod Opsins
  • Green Fluorescent Proteins